EUVIMEDEUVIMED entdecken
Open Access

Time to diagnosis among young patients with cancer

Lena E Winestone iD, Jennifer J Wilkes, Diane Puccetti, Theresa H M Keegan, Henry J Henk, Jeffrey McPheeters, Justine M Kahn iD, Jill Ginsberg, Samantha Wong, Sage Timberline, Marcio Malogolowkin, Brad H Pollock und 1 weitere

Pediatric Blood & Cancer · 2024-09 · 71 (9)

DOI: 10.1002/pbc.30997 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Blood & Cancer, online erschienen am 12.06.2024. Verfasst von Lena E Winestone und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Allergy, Immunology, and BMT, University of California, San Francisco Benioff Children's Hospital, San Francisco, California, USA. Hauptthemen laut MEDLINE: Neoplasms, Delayed Diagnosis. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: American Cancer Society and a Young Investigator Award from Cannonball Kids' cancer Foundation, NICHD NIH HHS, Leukemia Lymphoma Society Scholar in Clinical Research Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Sociodemographic and clinical factors associated with diagnostic delays in pediatric, adolescent, and young adult cancers are poorly understood.

Methods

Using the Optum Labs Data Warehouse's de‐identified claims data for commercial health plan enrollees, we identified children (0–14 years) and adolescents/young adults (AYAs) (15–39 years) diagnosed with one of 10 common cancers from 2001 to 2017, who were continuously enrolled for 6 months preceding diagnosis. Time to diagnosis was calculated as days between first medical encounter with possible cancer symptoms and cancer diagnosis date. Median times from first symptom to diagnosis were compared using Wilcoxon rank sum test. Multivariable unconditional logistic regression identified sociodemographic factors associated with longer time (>3 months) to cancer diagnosis (from symptom onset).

Results

Of 47,296 patients, 87% presented prior to diagnosis with symptoms. Patients with central nervous system (CNS) tumors were most likely to present with symptoms (93%), whereas patients with cervical cancer were least likely (70%). Symptoms varied by malignancy. Of patients with symptoms, thyroid (105 days [range: 50–154]) and cervical (104 days [range: 41–151]) cancer had the longest median time to diagnosis. Females and patients at either end of the age spectrum were more likely to experience diagnosis delays of more than 3 months.

Conclusion

In a commercially insured population, time to diagnosis varies by cancer type, age, and sex. Further work is needed to understand the patient, provider, and health system‐level factors contributing to time from symptom onset to diagnosis, specifically in the very young children and the young adult patient population going forward.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsDelayed DiagnosisHumansFemaleMaleAdolescentChildYoung AdultAdultChild, PreschoolInfantInfant, NewbornFollow-Up StudiesPrognosisTime Factors

Stichwörter der Autor:innen

AYA oncologydelay in diagnosispediatric oncology

Autor:innen und Institutionen

  • Division of Allergy, Immunology, and BMT, University of California, San Francisco Benioff Children's Hospital, San Francisco, California, USA.
  • UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA.
  • Division of Pediatric Hematology and Oncology, University of California Davis School of Medicine, Sacramento, California, USA.
  • Division of Hematology-Oncology, Seattle Children's Hospital, Seattle, Washington, USA.
  • University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
  • Center for Oncology Hematology Outcomes Research and Training (COHORT), Division of Hematology and Oncology, University of California Davis, School of Medicine, Sacramento, California, USA.

ORCID-Profile: Lena E Winestone, Justine M Kahn, Elysia Alvarez

Förderung

  • American Cancer Society and a Young Investigator Award from Cannonball Kids' cancer Foundation
  • NICHD NIH HHS
  • Leukemia Lymphoma Society Scholar in Clinical Research Program
  • KL2 Career Development Award
  • Stand Up 2 Cancer
  • Entertainment Industry Foundation

Zitieren

APA

Winestone, L. E., Wilkes, J. J., Puccetti, D., Keegan, T. H. M., Henk, H. J., McPheeters, J., Kahn, J. M., Ginsberg, J., Wong, S., Timberline, S., Malogolowkin, M., Pollock, B. H., & Alvarez, E. (2024). Time to diagnosis among young patients with cancer. Pediatric Blood & Cancer, 71(9). https://doi.org/10.1002/pbc.30997

Vancouver

Winestone LE, Wilkes JJ, Puccetti D, Keegan THM, Henk HJ, McPheeters J, et al. Time to diagnosis among young patients with cancer. Pediatric Blood & Cancer. 2024;71(9). doi:10.1002/pbc.30997

BibTeX
@article{Winestone2024,
  author = {Winestone, Lena E and Wilkes, Jennifer J and Puccetti, Diane and Keegan, Theresa H M and Henk, Henry J and McPheeters, Jeffrey and Kahn, Justine M and Ginsberg, Jill and Wong, Samantha and Timberline, Sage and Malogolowkin, Marcio and Pollock, Brad H and Alvarez, Elysia},
  title = {Time to diagnosis among young patients with cancer},
  journal = {Pediatric Blood & Cancer},
  year = {2024},
  volume = {71},
  number = {9},
  doi = {10.1002/pbc.30997}
}
Kostenlos starten →